Cardiology Flashcards
Stable ischemic heart disease (stable angina)
- atherosclerosis of coronary artery
- is the progression of atherosclerosis (a plaque), until it reaches a critical stenosis
- stenosis reaches 70%
- presence of angina by exertion
- no troponin
- no ST elevated segment
Acute coronary syndrome
- rupture & thrombosis of the plaque
- the occlusion of the coronary artery
Types:
1. unstable angina
2. STEMI
3. NSTEMI
Unstable angina
- rupture of thrombosis ( < 100%)
- presence of angina at rest (worst than stable angina)
- absence of troponin & ST elevation
NSTEMI
- rupture of thrombosis ( < 100%)
- Presence of angina at rest
- presence of troponin (myocardial infarction biomarker)
- absence of ST elevation
STEMI
-rupture of thrombosis ( 100%)
- Presence of angina at rest
- presence of troponin & ST elevation
- immediate cardiovascular catheterization (PCI within 90 min ) or ( fibrinolytic within 120 min)
Criteria of ACS
- Substernal crushing chest pain (tightness, heaviness)= angina = anginal equivalent ( if they had it before ?, is it similar to previous pain?)
- Worsen by excertion
- Relieved by nitroglycerin
- Associated symptoms : dyspnea, pre-syncope, N/V
- Risk factors:
- age ( male > 45; Female > 55)
- family history (early atherosclerosis)
- Diabetes, CKD, vasculopathy (atherosclerosis somewhere else)
- HTN, smoking, obesity, dyslipidemia - Physical exam:
- non tender angina
- nonplueritic angina
- non positional angina - Laboratory:
- 12-lead ECG ( rule out STEMI)
- Troponin- I ( Sensitive cardiac troponin, diagnose NSTEMI)
- APPROACH:
- invasive test: PCI
- non-invasive test ( anatomic, functional)—> in outpatient setting (chest pain):- Low risk: no test
- Intermediate/High risk:
- test based on age
- (if patient is < 65 = rule out; coronary CT angiogram (CCTA); anatomic testing)
- CABG + DAPT: if > 3 vessels are obstructed; if left mainstem equivalent; unaccessible
- PCI + DAPT: therapeutic CATH. (Compress plaque) - ( If patient age > 65 = rule in diagnosis; stress test; functional testing= stress the heart, make it work harder or take of blood supply)
- Stress: ( if patient can walk: treadmill) ( if patient cant walk: dobutamine, adenosine, dipyridomole)
- Test: ( ECG = ABNORMAL; use ECHO= wall motion abnormalities during stress= ABNORMAL; use Nuclear test & SPECT). ( MRI ?)
- (if patient is < 65 = rule out; coronary CT angiogram (CCTA); anatomic testing)
- test based on age
- Management:
“ aspirin + statin+ BB + ARB/ACE-I + DAPT (P2Y12) - Aspirin = 81 mg
- P2Y12= clopidogrel, prasugrel, ticagrelor
- Statin = high-potency (atrovastatin, rosuvostatin)
- BB: metoprolol (control HR) ; Carvedilol (control BP)
- ARB or ACE-I (cause angioedema and dry cough):
- Anti-anginal: nitrates (nitroglycerin; isosorbide mononitrate); dihydropyridine CCB (amlodipine, nifedipine), palliative (ranolazine)
NOTE:
- DAPT: Dual anti-platelet therapy ( Aspirin + P2Y12 = clopidogril, prasugrel, ticagrelor)
- CAGB: Coronary artery bypass grafting
- BB: NOT NECESSARY if (no history of infarction, no reduction in EF, Patient didn’t receive CABG)
- IF perform angioplasty alone (without stent)= no duration of DAPT
- IF STENT present = BMS= DAPT (for a month); DES = DAPT ( for a year; aspirin for 6 months; P2Y12 for 3 months)
Acute coronary syndrome
Path:
- rupture & thrombosis
- supply ischemia ( revascularize only way to fix this)
Pt:
- angina @ rest
Diagnosis:
- ECG (rule out ST elevation MI)
-Troponin ( to rule out non- ST elevation MI)
- invasive coronary angiogram (ICA) (CATH; )
12- LEAD ECG anatomic map
I
II
III
Patient with non-ischemic cardiomyopathy treated for atrial fibrillationn
- digoxin toxicity lead to GI symptoms ( anorexia, nausea) + weakness + confusion + lead to life-threatening arrhythmia
- digoxin can interact with amiodarone (or verapamil, quinidine, propafenone) & result in increase digoxin level in blood
- solution:
Decrease digoxin done by 25-50% when initiating amiodarone (or verapamil, quinidine, propafenone therapies)
What conditions lead to atrial fibrillation ?
Conditions that lead to atrial dilation &/or conduction remodeling:
- Advanced age
- Systemic HTN
- Mitral valve dysfunction
- LV failure
- CAD & related factors ( DM, smoking)
- Obesity & obstructive sleep apnea
- Chronic hypoxic lung disease (COPD)
Triggers of increased automaticity:
1. hyperthyroidism
2. excessive alcohol use
3. increased sympathetic tone: acute illness (sepsis, MI, PE), cardiac surgery.
4. sympathomimetic drugs ( cocaine)
Note:
-AF: varying R-R interval (irregularly irregular) + absence of organized P wave
- symptoms: palpitation, SOB, Chest pain, lightheadedness, weakness
- check new onset of AF:
1. Echo: evaluate valve disease, LV dysfunction or RV dilation/strain in PE
2. Serum TSH: evaluate hyperthyroidism
3. CT angio: evaluate PE (SOB, pleuritic chest pain) + ECHO (shows RV dilation or strain
4. Exercise stress testing: evaluate for CAD ( seen in old patients)
PAD ( & risk of CVD)
- intermittent claudication + ABI (< 0.9)
-use Combination of aspirin + statin - heparin used in acute thrombotic occlusion in PAD
- surgical revascularization is reserved for patients with:
1. Limb threatening complication ( unhealed ulcer)
2. limitation in activities of daily living
3. Failure to response to exercise
4. Failure to response to drugs
Infective endocarditis (IE) with IV drug use
Patho:
- injected particles (dirts…) damage the Right valves before going to the lungs
- bacterial growth
- increase risk for HIV
Feature:
- tricuspid valve regurgitation (most common affected)
- holosystolic murmur that increases in intensity with inspiration
- Staph. Aureus (most common organism)
- septic pulmonary emboli ( cough, Chest pain, hemoptysis + round lesions in peripheral lung field)
- peripheral manifestation (splinter hemorrhage, painless janeway lesion)
- heart failure is uncommon
- Septic pulmonary embolism (SPE)—> vegetations on a heart valve or a pacemaker lead or a thrombus in an indwelling vascular catheter or graft.
Aortic regurgitation
- diastolic murmur best heard when patient is sitting up
Infective endocarditis
- lead to tricuspid valve regurgitation + septic pulmonary emboli
Or
- lead to aortic regurgitation + No septic pulmonary emboli
Paradoxical splitting of S2
Seen with
Widened splitting ( on inspiration & expiration)
- Delayed P2:
- pulmonic stenosis
- pulmonic HTN
- ASD (wide & fixed splitting)
-RBBB - Early A2:
-VSD - Narrowed splitting (on inspiration) + paradoxical splitting ( on expiration)
- aortic stenosis
- systemic HTN
- LBBB
-HMC
Audible S4 (when patient is in the left lateral decubitus position)
-heard just before S1
- Caused by: blood striking a stiff LV wall (during atrial contraction)
- normally seen in elderly (> 70)
- abnormally seen in children —> indicated:
1. concentric LV hypertrophy ( associated with aortic stenosis or chronic HTN)
2. Restrictive cardiomyopathy (sarcoidosis, amyloidosis, hemochromatosis, cancer, fibrosis)
3. Acute myocardial infraction (MI)
Hypertrophic cardiomyopathy (HCM)
- Systolic murmur that increase in intensity when standing up or valsalva maneuver
- systolic murmur that decrease in intensity when squatting or handgrip
Audible S3
- heard just after S2
- caused by: reverberant sound as blood fills an enlarged LV cavity during passive diastolic filling
Seen with:
1. HFrEF
2. High-output states ( hyperthyroidism)
3. Mitral or aortic regurgitation
Syncope
- syncope occurs at rest or while sitting & without warning symptoms is suggestive for arrhythmic- cardiac etiology
Pericarditis (pleuritic chest pain, decrease with sitting, increase with laying supine, friction rib)
- developed less than 4 days after MI
- patient with delayed coronary perfusion following STEMI ( > 3 hours from symptom onset) are at increased risk of developing —> peri-infarction pericarditis (PIP)
- Sign on ECG: diffused ST elevation + PR depression
- sign on ECHO: pericardial effusion
- treatment:
1. Supportive
2. Avoid: NSAID, GC (increase risk for ventricular wall rupture —> pericardial effusion —> cardiac tamponade)
Acute stabilization of ST- elevation in MI
Initial management:
1. Supplement oxygen (if SaO2 < 90%)
2. Aspirin (full dose, chewable)
3. P2Y12 inhibitor (clopidogrel)
4. Sublingual nitroglycerin ( caution with hypotension or RV infarct)
5. Beta-blocker ( avoid in hypotension, bradycardia, or HF)
6. High potency statin ( atorvastatin)
7. Anticoagulation ( heparin infusion)
Additional stabilization (if needed)
1. Persistent chest pain —> IV NTG or morphine
2. Hypertension —> IV NTG
3. Pulmonary edema —> furosemide +/- NTG
4. Unstable bradycardia —> IV atropine
Emergency re-perfusion:
1. PCI within 90 minutes
2. Thrombolysis within 120 minutes (if PCI is not available)
Ventricular fibrillation or pulseless ventricular tachycardia
Managed with defibrillator
Hemodynamic unstable patient with narrow or wide QRS complex tachycardia ( atrial fibrillation, atrial flutter, ventricular tachycardia with a pulse)
- managed with synchronized cardioeversion
Atrial fibrillation
- absent P-wave & irregularly irregular R-R interval
- located at: pulmonary vein
- managed with: hemodynamic unstable (synchronized cardioeversion)
- can be treated surgically with: catheter-based pulmonary vein ablation ( burn or freeze to break up electrical signals that causes irregular beat)
Sick sinus syndrome (SSS)
- caused by: degeneration of sinus node & replacement with fibrous tissue
- elderly people most commonly affected
- present with bradycardia ( fatigue, dizziness, syncope dyspnea on exertion)
- ECG finding: sinus bradycardia + dropped or delayed P-wave
Morbitz type 1 vs. morbitz type 2
Morbitz type 1
- progressive prolongation in PR interval & a drop in QRS complex
- occurs in AV node
Morbitz type 2
- constant prolongation in PR interval & random drop in QRS complex
- occurs in His-Purkinji system